Rapid Therapeutic Science Laboratories, Inc.
RTSL
$0.0074
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -75.74% | 291.21% | 121.53% | -517.12% | 97.67% |
| Total Depreciation and Amortization | 708.33% | 110.38% | -311.72% | -43.71% | 708.33% |
| Total Amortization of Deferred Charges | 74.92% | -75.31% | -58.88% | -58.27% | 14.05% |
| Total Other Non-Cash Items | 73.82% | -65.57% | 51.34% | 45.76% | -922.58% |
| Change in Net Operating Assets | -180.58% | 131.06% | -251.24% | 23.84% | -9.25% |
| Cash from Operations | 82.54% | 88.13% | -112.82% | -353.68% | 109.32% |
| Capital Expenditure | -- | -- | -- | 100.00% | -807.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 100.00% | -807.95% |
| Total Debt Issued | -140.19% | -62.98% | 100.89% | -69.87% | -35.14% |
| Total Debt Repaid | 40.08% | 87.22% | -220.47% | -50.00% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -113.64% | 63.19% | -31.71% | -84.02% | -41.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -187.50% | -- | 100.00% | -241.67% | 149.66% |